Acetaminophen

Awareness of acetaminophen safe use and the risks of using too much remains high, indicating that ongoing education is critical to continued progress.

We don't often think about insurance coverage for OTC medicines, but more and more health plans are offering this benefit. In this episode, we'll explore what new research is telling us about this and why Medicare Advantage is a big opportunity for self-care.

Anita Brikman sits down with board-certified pediatrician and co-founder of Forever Freckled, Dr. Katie Friedman to discuss the rise of the healthcare social media influencer.

Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.

Acetaminophen was chosen for review by OEHHA in part because the Prop 65 regulation emphasizes chemicals with “widespread exposure.” The Carcinogen Identification Committee will review the information on acetaminophen and cancer to determine whether acetaminophen should be listed as a carcinogen under Proposition 65.

CHPA supports and encourages continued research and promotes ongoing consumer education to help ensure safe use of OTC medicines.